AstraZeneca Italy

AstraZeneca Italy, founded in 1963, operates as a key player in the Pharmaceutical and Healthcare sectors, focused on delivering value through innovative medicines. The company specializes in critical therapeutic areas, including cardiovascular and metabolic diseases, oncology, and respiratory, inflammatory, and autoimmune conditions. Its mission is to address unmet medical needs and improve patient outcomes by advancing scientific understanding and therapeutic development within Italy.

The company maintains a robust operational framework with an employee range of 500-1,000 employees. AstraZeneca Italy is deeply committed to sustainability and upholds rigorous quality policies, ensuring a responsible and effective approach to healthcare. This dedication is reflected in its team's efforts and operational efficiency. Further details about the personnel driving these advancements can be found by exploring Meet AstraZeneca Italy's team. The company's operations are centralized, with a single primary location supporting its strategic objectives.

AstraZeneca Italy's primary goal is to provide patients and healthcare professionals with access to advanced treatment options, generating approximately $61.0M in revenue. Through its specialized product offerings, the company strives to significantly impact the management of various health conditions. Its official website, www.astrazeneca.it, offers comprehensive information on its portfolio and corporate activities. AstraZeneca Italy's commitment to innovation and quality solidifies its role in advancing the Italian healthcare landscape and contributing to public health.